Pharmacoepidemiology and Drug Safety

Cover image for Vol. 26 Issue 7

Edited By: B.L. Strom, USA; S. Hennessy, USA; H. G. M. Leufkens, The Netherlands; B.J. Park, Korea

Impact Factor: 2.552

ISI Journal Citation Reports © Ranking: 2016: 47/176 (Public Environmental & Occupational Health); 121/256 (Pharmacology & Pharmacy)

Online ISSN: 1099-1557

The Ronald D. Mann Best Paper Award

Pharmacoepidemiology and Drug Safety presents The Ronald D. Mann Best Paper Award each year to the first author of the strongest contribution within a given volume, as determined by the Editors and a representative of the International Society for Pharmacoepidemiology (ISPE).

The Award is open to all authors. Certificates and prizes are awarded at ISPE's annual meeting. The award is named for the Founding Editor of the journal, and provided by the publisher, John Wiley & Sons Limited.

2016 (Volume 25)

First Prize
Case–control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke
James S. Floyd, Kerri L. Wiggins, et al.

Honourable Mentions
Trimethoprim–sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies
Craig Hansen, Susan E. Andrade, et al.

Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study
Maja Hellfritzsch, Jette Rathe, et al.

Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes
Ahmed S. Abdelmoneim, Dean T. Eurich, et al.

2015 (Volume 24)

Hung-Lin Chen and Fei-Yuan Hsiao.
Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case–crossover study

Honourable Mention

Joshua A. Roth, Katharine Bradley, Kenneth E. Thummel, David L. Veenstra, and Denise Boudreau.
Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting

Natalie C. Momen, Jørn Olsen, Mika Gissler, Helle Kieler, Bengt Haglund and Jiong Li
Exposure to systemic antibacterial medications during pregnancy and risk of childhood cancer

2014 (Volume 23)

Jürgen Prestel, Peter Volkers, Dirk Mentzer, Helmar C. Lehmann, Hans-Peter Hartung, and Brigitte Keller-Stanislawski, for the GBS Study Group.
Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.

Honourable Mention

Yuelian Sun, Chun Sen Wu and Jørn Olsen.
Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control design.

Marsha A. Raebel, Sophia R. Newcomer, Elizabeth A. Bayliss, Denise Boudreau, Lynn DeBar, Thomas E. Elliott, Ameena T. Ahmed, Pamala A. Pawloski, David Fisher, Sengwee Toh and William Troy Donahoo
Chronic opioid use emerging after bariatric surgery.

Douglas C. McDonald and Kenneth E. Carlson.
The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers (“doctor shopping”).

2013 (Volume 22)

Best Article

Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

Honourable Mention

Shahed Iqbal, John P. Barile, William W. Thompson and Frank DeStefano
Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7–10 years

Carlos Iribarren, Alfred D. Round, Jonathan A. Peng, Meng Lu, Jonathan G. Zaroff, Taylor J. Holve, Amit Prasad and Paul Stang
Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study

Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery
Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly

2011 (Volume 20) Finalists

Best Article
John Paul Leombruno, Geoffrey C Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis
(p 838 - 848) Vol 20 Issue 8

Honourable Mention
Daren Lin, Jamie A Seabrook, Doreen M Matsui, Susan M King, Michael J Rieder, Yaron Finkelstein. Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada
(p 1246 - 1252) Vol 20, Issue 12

Honourable Mention
Robert L Davis, David Eastman, Heather McPhillips, Marsha A Raebel, Susan E Andrade, David Smith, Marianne Ulcickas Yood, Sascha Dublin and Richard Platt. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy.
(p 138 - 145) Vol 20, Issue 2.

Honourable Mention
Henriette Thisted Horsdal, Flemming Søndergaard, Søren Paaske Johnsen, Jørgen Rungby. Antidiabetic treatments and risk of hospitalisation with Myocardial infarction: a nationwide case-control study.
(p 331-337) Vol 20, Issue 4.

2010 (Volume 19)

Wendy Klein-Schwartz, John David Sorkin and Suzanne Doyon. Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers.
(p 819-824) Vol 19 Issue 8

Honorable Mention
Laurent Azoulay, Verena Schneider-Lindner, Sophie Dell'Aniello, Alicia Schiffrin and Samy Suissa. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
(p 335-342) Vol 19 Issue 4

Honorable Mention
Alain Weill, Michel Païta, Philippe Tuppin, Jean-Paul Fagot, Anke Neumann, Dominique Simon, Philippe Ricordeau, Jean-Louis Montastruc and Hubert Allemand. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
(p 1256-1262) Vol 19 Issue 12

Honorable Mention
Eric S Johnson, Jessica R Weinstein, Micah L Thorp, Robert W Platt, Amanda F Petrik, Xiuhai Yang, Sharon Anderson and David H Smith. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.
(p 266-272) Vol 19 Issue 3

2009 (Volume 18)

Traditional versus marginal structural models to estimate the effectiveness of β-blocker use on mortality after myocardial infarction
Joseph A. C. Delaney, Stella S. Daskalopoulou, Samy Suissa
Volume 18, Issue 1, January 2009, Pages: 1-6

Abstract  |  References  | Full Text: PDF (Size: 79K)

Emergency department visits attributed to selected analgesics, United States, 2004–2005
Mary Willy, Judith P. Kelly, Parivash Nourjah, David W. Kaufman, Daniel S. Budnitz, Judy Staffa
Volume 18, Issue 3, March 2009, Pages: 188-195

Abstract  |  References  | Full Text: PDF (Size: 113K)

Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?
Yan Chen, Jeff J. Guo, Nick C. Patel
Volume 18, Issue 3, Marchl 2009, Pages: 196-202

Abstract  |  References  | Full Text: PDF (Size: 84K)

2008 (Volume 17)

Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs
Judith P. Kelly, Patricia Coogan, Brian L. Strom, Lynn Rosenberg
Volume 17, Issue 4, April 2008, Pages: 322-327

Abstract  |  References  | Full Text: PDF (Size: 74K)

Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity
James D. Lewis, Brian L. Strom, A. Russell Localio, David C. Metz, John T. Farrar, Robert M. Weinrieb, Lisa Nessel, Colleen Brensinger, Stephen E. Kimmel
Volume 17, Issue 4, April 2008, Pages: 328-335

Abstract  |  References  | Full Text: PDF (Size: 90K)

Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs
Tarek A. Hammad, David J. Graham, Judy A. Staffa, Cynthia J. Kornegay, Gerald J. Dal Pan
Volume 17, Issue 4, April 2008, Pages: 315-321

Abstract  |  References  | Full Text: PDF (Size: 123K)

2007 (Volume 16)

Early detection of adverse drug events within population-based health networks: application of sequential testing methods
Jeffrey S. Brown, Martin Kulldorff, K. Arnold Chan, Robert L. Davis, David Graham, Parker T. Pettus, Susan E. Andrade, Marsha A. Raebel, Lisa Herrinton, Douglas Roblin, Denise Boudreau, David Smith, Jerry H. Gurwitz, Margaret J. Gunter, Richard Platt
Volume 16, Issue 12, December 2007, Pages: 1275-1284

Abstract  |  References  | Full Text: PDF (Size: 138K)

The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database
Kristian B. Filion, J. A. Chris Delaney, James M. Brophy, Pierre Ernst, Samy Suissa
Volume 16, Issue 1, January 2007, Pages: 1-4

Abstract  |  References  | Full Text: PDF (Size:87K)

Risk of local adverse events by gender following cardiac catheterization
Dale R. Tavris, Beverly Albrecht Gallauresi, Syamal Dey, Ralph Brindis, Kristi Mitchel
Volume 16, Issue 2, Date: February 2007, Pages: 125-131

Abstract  |  References  | Full Text: PDF (Size:117K)

2006 (Volume 15)

FDA drug prescribing warnings: is the black box half empty or half full?
Anita K. Wagner, K. Arnold Chan, Inna Dashevsky, Marsha A. Raebel, Susan E. Andrade, Jennifer Elston Lafata, Robert L. Davis, Jerry H. Gurwitz, Stephen B. Soumerai, Richard Platt
Volume 15, Issue 6, June 2006, Pages: 369-386

Abstract  |  References  | Full Text: HTML , PDF (Size: 143K)

Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications
Priscilla Velentgas, William West, Carolyn C. Cannuscio, Douglas J. Watson, Alexander M. Walker
Volume 15, Issue 9, September 2006, Pages: 641-652

Abstract  |  References  | Full Text: HTML , PDF (Size: 121K)

2005 (Volume 14)

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program
Robert J. Cluxton Jr, Zili Li, Pamela C. Heaton, Sheila R. Weiss, Ilene H. Zuckerman, Charles J. Moomaw, Van Doren Hsu, Evelyn M. Rodriguez
Volume 14, Issue 1, January 2005, Pages: 1-9

Abstract  |  References  | Full Text: HTML , PDF (Size: 201K)

Benzodiazepines and injury: a risk adjusted model
Dustin D. French, Robert Campbell, Andrea Spehar, David M. Angaran
Volume 14, Issue 1, Date: January 2005, Pages: 17-24

Abstract  |  References  | Full Text: HTML , PDF (Size: 93K)

Selective prescribing of atypical antipsychotics
Nancy S. Breekveldt-Postma, Igor Schillevoort, Willem A. Nolen, Christiaan P. W. M. Veraart, Ron M. C. Herings
Volume 14, Issue 1, Date: January 2005, Pages: 25-30

Abstract  |  References  | Full Text: HTML , PDF (Size: 67K)

Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials
Giovanni Corrao, Edoardo Botteri, Vincenzo Bagnardi, Antonella Zambon, Alessandra Carobbio, Chiara Falcone, Olivia Leoni
Volume 14, Issue 1, Date: January 2005, Pages: 31-40

Abstract  |  References  | Full Text: HTML , PDF (Size: 103K)

Small proportions: what to report for confidence intervals?
Hilde Tobi, Paul B. van den Berg, Lolkje TW de Jong-van den Berg
Volume 15, Issue 3, Date: March 2006, Pages: 211

Abstract  |  References  | Full Text: PDF (Size: 202K)

2004 (Volume 13)

Application of a propensity score to adjust for channelling bias with NSAIDs
S. V. Morant, D. Pettitt, T. M. MacDonald, T. A. Burke, J. L. Goldstein
Volume 13, Issue 6, June 2004, Pages: 345-353

Abstract  |  References  | Full Text: HTML , PDF (Size: 85K)

High frequency of use of rofecoxib at greater than recommended doses: cause for concern
Marie R. Griffin, C. Michael Stein, David J. Graham, James R. Daugherty, Patrick G. Arbogast, Wayne A. Ray
Volume 13, Issue 6, June 2004, Pages: 339-343

Abstract  |  References  | Full Text: HTML , PDF (Size: 90K)

Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study)
Arnulf Langhammer, Ensio Norjavaara, Maria Gerhardsson de Verdier, Roar Johnsen, Leif Bjermer
Volume 13, Issue 8, Date: August 2004, Pages: 569-579

Abstract  |  References  | Full Text: HTML , PDF (Size: 152K)

Infant vaccinations and childhood asthma among full-term infants
Julie E. Maher, John P. Mullooly, Lois Drew, Frank DeStefano
Volume 13, Issue 1, Date: January 2004, Pages: 1-9

Abstract  |  References  | Full Text: HTML , PDF (Size: 89K)

2003 (Volume 12)

The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD
H. E. Seaman, C. S. de Vries, R. D. T. Farmer
Volume 12, Issue 7, October/November 2003, Pages: 541-550

Abstract  |  References  | Full Text: HTML , PDF (Size: 94K)

Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
Ron M. C. Herings, Joëlle A. Erkens
Volume 12, Issue 5, July/August 2003, Pages: 423-424

Abstract  |  References  | Full Text: HTML , PDF (Size: 36K)

Liver function testing in patients on HMG-CoA reductase inhibitors
Susan E. Andrade, James G. Donahue, K. Arnold Chan, Douglas J. Watson, Richard Platt
Volume 12, Issue 4, Date: June 2003, Pages: 307-313

Abstract  |  References  | Full Text: HTML , PDF (Size: 84K)

A case-control study of acetaminophen use in relation to the risk of first myocardial infarction in men
Lynn Rosenberg, R. Sowmya Rao, Julie R. Palmer
Volume 12, Issue 6, Date: September 2003, Pages: 459-465

Abstract  |  References  | Full Text: HTML , PDF (Size: 71K)

Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment
Sonia Tabacova, Ruth Little, Yi Tsong, Amarilys Vega, Carole A. Kimmel
Volume 12, Issue 8, Date: December 2003, Pages: 633-646

Abstract  |  References  | Full Text: HTML , PDF (Size: 120K)

2002 (Volume 11)

Wheezing lower respiratory disease and vaccination of full-term infants
John P. Mullooly, John Pearson, Lois Drew, Roberleigh Schuler, Julie Maher, Paul Gargiullo, Frank DeStefano, Robert Chen
Volume 11, Issue 1, January/February 2002, Pages: 21-30

Abstract  |  References  | Full Text: HTML , PDF (Size: 132K)

Estrogen replacement therapy and risk of lung cancer
Janine A. Blackman, Patricia F. Coogan, Lynn Rosenberg, Brian L. Strom, Ann G. Zauber, Julie R. Palmer, Patricia Langenberg, Samuel Shapiro
Volume 11, Issue 7, Date: Oct-Nov 2003, Pages: 561-7

Abstract  |  References  | Full Text: HTML , PDF (Size: 72K)

Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999
James Cross, Howard Lee, Agnes Westelinck, Julie Nelson, Charles Grudzinskas, Carl Peck
Volume 11, Issue 6, Date: September 2002, Pages: 439-446

Abstract  |  References  | Full Text: HTML , PDF (Size: 88K)

Changes in prescribed drug doses after market introduction
Eibert R. Heerdink, John Urquhart, Hubert G. Leufkens
Volume 11, Issue 6, Date: September 2002, Pages: 447-453

Abstract  |  References  | Full Text: HTML , PDF (Size: 80K)

Parenteral ketorolac and risk of myocardial infarction
Stephen E. Kimmel, Jesse A. Berlin, Judith L. Kinman, Sean Hennessy, Harold Feldman, Jeffrey L. Carson, Brian L. Strom
Volume 11, Issue 2, Date: March 2002, Pages: 113-119

Abstract  |  References  | Full Text: HTML , PDF (Size: 76K)

2001 (Volume 10)

Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use
Chantal Bourgault, Eleanor Elstein, Marc A. Baltzan, Jacques Le Lorier, Samy Suissa
Volume 10, Issue 4, June/July 2001, Pages: 287-294
Abstract  |  References  | Full Text: HTML , PDF (Size: 88K)